Speech Topic: The Emergence of China Biotech Innovation
演讲题目：中国创新医药的崛起
Cynthia Wang, the General Manager of the I&BD Department of SERVIER (China) (施维雅中国)
Speech Topic: New Era of Innovation and Differentiatio
演讲题目：创新与差异化的新时代
Jiaxi Xu, the Chief Analyst of Industrial Securities(兴业证券)
Speech Topic: Cross-border Licensing Annual review
演讲题目：医药跨境交易年度汇总
Sean Jiang, the CEO and Founder of YAFO Capital (雅法资本)
Speech Topic: Status Quo and Future Development of Cell Therapy in China
演讲题目 ：细胞疗法在中国的现状与未来
Richard Wang, the Founder, Chairman and CEO of Neukio Biotherapeutics(星奕昂生物)
Speech Topic: Advances in Gene Therapy and Future Prospect
演讲题目：基因治疗现状与未来展望
Alvin Luk, the CEO of NEUROPHTH THERAPEUTICS Inc.(纽福斯生物)
Speech Topic: China to Global—License out strategy
演讲题目 ：License-out: 中国企业面对MNC的谈判策略
Andy Fu, the Co-Founder & CBO of OnCusp Therapeutics(昂阔医药)
Speech Topic: Chinese Large-cap Pharma License-in/out Strategy-Huadong Medicine Perspectives
演讲题目：中国大型药企license-in/out的交易策略 – 华东医药视角
Richard Yu, the General Manager of the I&BD Department of Huadong Medicine(华东医药)
Speech Topic: Translating Immunology into New Therapies for Autoimmune Diseases
Hung-Kai Kevin Chen, Chairman & CEO (Elixiron Immunotherapeutics)
Speech Topic: Israel as a tech-hub for medical technologies
Ofir Hazut (Trendlines, VP Business Development)
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 